353 related articles for article (PubMed ID: 6327014)
1. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance.
Milas L; McBride WH; Hunter N; Ito H
Cancer Res; 1984 Jun; 44(6):2382-6. PubMed ID: 6327014
[TBL] [Abstract][Full Text] [Related]
2. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
Milas L; Ito H; Hunter N
Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice.
Milas L; Hunter N; Reid BO; Thames HD
Cancer Res; 1982 May; 42(5):1888-97. PubMed ID: 6279288
[TBL] [Abstract][Full Text] [Related]
4. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation-induced leg contractures in mice.
Hunter N; Milas L
Cancer Res; 1983 Apr; 43(4):1630-2. PubMed ID: 6831410
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of radiation carcinogenesis in mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.
Milas L; Hunter N; Stephens LC; Peters LJ
Cancer Res; 1984 Dec; 44(12 Pt 1):5567-9. PubMed ID: 6093999
[TBL] [Abstract][Full Text] [Related]
6. Leech salivary gland extract from Haementeria officinalis, a potent inhibitor of cyclophosphamide- and radiation-induced artificial metastasis enhancement.
Gasic GJ; Iwakawa A; Gasic TB; Viner ED; Milas L
Cancer Res; 1984 Dec; 44(12 Pt 1):5670-6. PubMed ID: 6498828
[TBL] [Abstract][Full Text] [Related]
7. Studies on the antitumor activities of pyrimidinone-interferon inducers. I. Effect against artificial and spontaneous lung metastases of murine tumors.
Milas L; Hersh EM; Stringfellow DA; Hunter N
J Natl Cancer Inst; 1982 Jan; 68(1):139-45. PubMed ID: 6172625
[TBL] [Abstract][Full Text] [Related]
8. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
Mason KA; Ariga H; Neal R; Valdecanas D; Hunter N; Krieg AM; Whisnant JK; Milas L
Clin Cancer Res; 2005 Jan; 11(1):361-9. PubMed ID: 15671567
[TBL] [Abstract][Full Text] [Related]
9. Incidence of tissue toxicities in gamma ray and fission neutron-exposed mice treated with Amifostine.
Paunesku D; Paunesku T; Wahl A; Kataoka Y; Murley J; Grdina DJ; Woloschak GE
Int J Radiat Biol; 2008 Aug; 84(8):623-34. PubMed ID: 18661379
[TBL] [Abstract][Full Text] [Related]
10. Antimutagenic effects of amifostine: clinical implications.
Kataoka Y; Perrin J; Hunter N; Milas L; Grdina DJ
Semin Oncol; 1996 Aug; 23(4 Suppl 8):53-7. PubMed ID: 8783668
[TBL] [Abstract][Full Text] [Related]
11. Effect of X-rays and cyclophosphamide on solid tumors and naturally occurring metastases in mice.
Chu AM; Fowler JF
Cancer Res; 1982 May; 42(5):1943-9. PubMed ID: 7066905
[TBL] [Abstract][Full Text] [Related]
12. Suppression of delayed-type hypersensitivity to oxazolone in whole-body-irradiated mice and protection by WR-2721.
Srinivasan V; Weiss JF
Radiat Res; 1984 Jun; 98(3):438-44. PubMed ID: 6328568
[TBL] [Abstract][Full Text] [Related]
13. Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice.
Zietman AL; Suit HD; Ramsay JR; Silobrcic V; Sedlacek RS
Cancer Res; 1988 Nov; 48(22):6510-6. PubMed ID: 3052803
[TBL] [Abstract][Full Text] [Related]
14. Protection by WR-3689 against gamma-ray-induced intestinal damage: comparative effect on clonogenic cell survival, mouse survival, and DNA damage.
Murray D; Altschuler EM; Hunter N; Milas L
Radiat Res; 1989 Nov; 120(2):339-51. PubMed ID: 2559423
[TBL] [Abstract][Full Text] [Related]
15. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
[TBL] [Abstract][Full Text] [Related]
16. Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2.
Milas L; Hersh EM; Hunter N
Cancer Res; 1981 Jun; 41(6):2378-85. PubMed ID: 7237436
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of WR-151327: an orally active chemotherapy protector.
Green D; Bensely D; Schein P
Cancer Res; 1994 Feb; 54(3):738-41. PubMed ID: 8306335
[TBL] [Abstract][Full Text] [Related]
18. Drug combination against single drug treatment in radiation protection of the bone marrow CFU.
Bisht KS; Uma Devi P; Jagetia GC; Kamath G
Strahlenther Onkol; 1990 Aug; 166(8):545-8. PubMed ID: 2168583
[TBL] [Abstract][Full Text] [Related]
19. Effect of low doses of whole body irradiation on spontaneous lung metastasis of NFSA2ALM1 mouse tumors.
Suzuki N; Mizukoshi T
Radiat Med; 1987; 5(6):212-4. PubMed ID: 3330828
[TBL] [Abstract][Full Text] [Related]
20. Radioprotective effect of combinations of WR-2721 and mercaptopropionylglycine on mouse bone marrow chromosomes.
Uma Devi P; Prasanna PG
Radiat Res; 1990 Nov; 124(2):165-70. PubMed ID: 2174174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
